IONS — Ionis Pharmaceuticals Inc · rev $514.0M

Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.

Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.

Use this IONS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the IONS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the IONS SEC filings page. Lician reads the product cache first so this HTML stays unique to Ionis Pharmaceuticals Inc even when a live quote feed is slow.

Ionis Pharmaceuticals Inc latest statements (FY2025)

Latest cached year on this hub. Full IONS income, balance, and cash tables.

  • Revenue$203.3M
  • Net Income-$229.4M
  • Total Assets$3.52B
  • Total Debt$0
  • Free Cash Flow-$320.0M

IONS recent filings